Clinical molecular diagnostics and biomarker discoveries are constantly advancing in conjunction with an increasing number of therapeutics. Different biomarker technologies exist depending on the availability of the biological samples. Data interpretation of comprehensive genomic profiling is essential for individualized treatment. Currently, customized treatment for patients defines the standard of care. In the hematologic malignancies field the genomic landscape is better defined. The biomarkers in hematology day in 2020 was a great success with more than 6 international speakers from 4 countries, 50 participants from 10 countries and 20 fellows from 6 Lebanese Universities.

Register Now on: https://us06web.zoom.us/webinar/register/WN_tCQ3SMdGTdCQsk8MB21Bgg